Chrousos syndrome: a seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signalling changes
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Eur J Clin Invest 2010; 40 (10): 932–942 Background Glucocorticoids regulate a broad spectrum of physiologic functions and play important roles in resting and stress homeostasis. Their actions are mediated by the nuclear glucocorticoid receptor (GR). Design Using a patient as a stimulus, we reviewed briefly the area of Primary Generalized Glucocorticoid Resistance in man and nonhuman primates. Results In man, Primary Generalized Glucocorticoid Resistance is a rare sporadic or familial syndrome characterized by target‐tissue insensitivity to glucocorticoids and compensatory elevations in adrenocorticotropic hormone (ACTH), leading to increased secretion of cortisol and adrenal steroids with mineralocorticoid and/or androgenic activity, and causing hypermineralocorticoidism and hyperandrogenism without Cushing stigmata. The presentation, diagnosis and therapy of this condition are summarized. Many or, most likely, all New World primates have markedly elevated cortisol and ACTH, and resistance to dexamethasone suppression, without any pathology. These primates in fact have ‘pan‐steroid/sterol’ resistance, including all five steroid hormones and 1,25‐dihydroxy‐vitamin D. In humans, the molecular basis of Primary Generalized Glucocorticoid Resistance has been mainly ascribed to recent mutations in the GR gene, which impair glucocorticoid signal transduction. In contrast, in the primates, steroid/sterol signalling systems have adapted under yet unknown selective pressures or genetic drift over many million years. Of course, other molecules of the signaling pathways may also be involved in both states. There are now a host of human states associated with tissue‐specific pathologic glucocorticoid target tissue changes. These include allergic, autoimmune, inflammatory and lymphoproliferative disorders. Conclusions In recognition of Professor George P. Chrousos’ extensive ground‐breaking research in this field, and for the sake of brevity, we propose that ‘Chrousos syndrome’ is used instead of ‘Primary Generalized Familial or Sporadic Glucocorticoid Resistance’.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Variations in the pattern of pubertal changes in boys
Marshall, W. A., & Tanner, J. M. (1970) · Archives of Disease in Childhood · doi:10.1136/adc.45.239.13 · Cited by 5,147
Regulation of the acute production of steroids in steroidogenic cells
STOCCO, D. M., & CLARK, B. J. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-3-221 · Cited by 1,057
11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969
Cole, T. J., Blendy, J. A., Monaghan, A. P., Krieglstein, K., Schmid, W., Aguzzi, A., Fantuzzi, G., Hummler, E., Unsicker, K., & Schütz, G. (1995) · Genes & Development · doi:10.1101/gad.9.13.1608 · Cited by 946
Hurley, D. M., Accili, D., Stratakis, C. A., Karl, M., Vamvakopoulos, N., Rorer, E., Constantine, K., Taylor, S. I., & Chrousos, G. P. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115046 · Cited by 370
Steroid 5α-Reductase 2 Deficiency*
WILSON, J. D., GRIFFIN, J. E., & RUSSELL, D. W. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-5-577 · Cited by 346
Karl, M., Lamberts, S. W., Detera-Wadleigh, S. D., Encio, I. J., Stratakis, C. A., Hurley, D. M., Accili, D., & Chrousos, G. P. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.3.8445027 · Cited by 241
Discrimination between NL1- and NL2-Mediated Nuclear Localization of the Glucocorticoid Receptor
Savory, J. G. A., Hsu, B., Laquian, I. R., Giffin, W., Reich, T., Haché, R. J. G., & Lefebvre, Y. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1025 · Cited by 222
Charmandari, E., Kino, T., Ichijo, T., & Chrousos, G. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0040 · Cited by 201
Self-citationWestberry, J. M., Sadosky, P. W., Hubler, T. R., Gross, K. L., & Scammell, J. G. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.03.004 · Cited by 91
Research works printed but not linked: 30
- 10.1172/JCI110565 · DOI · Paper page
- 10.7326/0003-4819-119-11-199312010-00009 · DOI · Paper page
- 10.1210/jc.2009-2463 · DOI · Paper page
- 10.1210/edrv-17-3-245 · DOI · Paper page
- 10.1126/stke.3042005pe48 · DOI · Paper page
- Karl M, 1996, Cushing’s disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant‐negative glucocorticoid receptor mutation, Proc Assoc Am Physicians, 108, 296
- 10.1210/jc.76.3.683 · doi:10.1210/jc.76.3.683 · Paper page
- 10.1172/JCI116410 · DOI · Paper page
- Kino T, 2001, Pathologic human GR mutant has a transdominant negative effect on the wild‐type GR by inhibiting its translocation into the nucleus: importance of the ligand‐binding domain for intracellular GR trafficking, J Clin Endocrinol Metab, 86, 5600, 10.1210/jcem.86.11.8017 · DOI · Paper page
- 10.1046/j.1365-2265.2001.01323.x · DOI · Paper page
- 10.1210/jcem.87.4.8379 · doi:10.1210/jcem.87.4.8379 · Paper page
- 10.1210/jcem.87.6.8520 · doi:10.1210/jcem.87.6.8520 · Paper page
- 10.1210/jc.2003-030450 · DOI · Paper page
- 10.1210/jc.2004-1920 · DOI · Paper page
- 10.1210/jc.2005-1893 · DOI · Paper page
- 10.1210/jc.2006-2830 · DOI · Paper page
- Dahlman‐Wright K, 1991, Interaction of the glucocorticoid receptor DNA‐binding domain with DNA as a dimer is mediated by a short segment of five amino acids, J Biol Chem, 266, 3107, 10.1016/S0021-9258(18)49960-7 · DOI · Paper page
- Kino T, 2004, Glucocorticoid receptor mutants demonstrate increased motility inside the nucleus of living cells: time of fluorescence recovery after photobleaching (FRAP) is an integrated measure of receptor function, Mol Med, 12, 80, 10.2119/2005-00026.Kino · DOI · Paper page
- 10.1073/pnas.091553298 · DOI · Paper page
- 10.1126/science.1086185 · DOI · Paper page
- 10.1126/science.1123348 · DOI · Paper page
- 10.1073/pnas.79.6.2036 · DOI · Paper page
- Chrousos GP, 1985, The defective glucocorticoid receptor in man and nonhuman primates, Recent Prog Horm Res, 41, 199
- 10.1007/978-1-4684-5101-6 · DOI
- 10.1210/jc.84.12.4450 · DOI
- 10.1111/j.1749-6632.2009.04988.x · DOI · Paper page
- 10.1210/jc.2008-0892 · DOI · Paper page
- Ferriman D, 1961, Clinical assessment of body hair growth in women, J Clin Endocrinol Metab, 83, 2694
- 10.1136/adc.44.235.291 · DOI · Paper page
- 10.1210/jc.85.5.2076 · DOI · Paper page
Cited by
Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1710 · Cited by 1,769
“However, caution is required because adrenocortical function test re-sults may be severely affected by rare conditions such as cortisol-binding globulin (CBG) deficiency, glucocorticoid resistance, and hypersensitivity (33–36).”
BackgroundCharmandari, E., Nicolaides, N. C., & Chrousos, G. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61684-0 · Cited by 644
Self-citationThe Glucocorticoid Receptor: Isoforms, Functions, and Contribution to Glucocorticoid Sensitivity
Lockett, J., Inder, W. J., & Clifton, V. L. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae008 · Cited by 135
Gibbison, B., Angelini, G. D., & Lightman, S. L. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aet077 · Cited by 87
Nicolaides, N. C., Charmandari, E., Chrousos, G. P., & Kino, T. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-71 · Cited by 83
Self-citation
Metadata
- Authors
- Charmandari, E., & Kino, T.
- Venue
- European Journal of Clinical Investigation
- Publisher
- Wiley
- Published
- 2010-08-19
- Volume
- 40
- Issue
- 10
- Pages
- 932-942
- ISSN
- 0014-2972 (ISSN-L)
- 1365-2362
- OpenAlex
- W1959492836
- Cited by
- 61
- References
- 11
- FWCI
- 3.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chrousos syndrome: a seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signalling changes. https://app.cochat.ai/papers/10.1111/j.1365-2362.2010.02336.x
- The paper
- Charmandari, E., & Kino, T. (2010). Chrousos syndrome: a seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signalling changes. European Journal of Clinical Investigation. https://doi.org/10.1111/j.1365-2362.2010.02336.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.